| ||||
News, Publications, and Related Stories
Publication: Cancer Research -- Sept. 29, 2009 
Mayo Clinic Cancer Center receives an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center. 
Named professorships at Mayo Clinic represent the highest academic distinction for a faculty member. Cancer Center member Svetomir Markovic, M.D., Ph.D., who holds the academic rank of professor of medicine and associate professor of oncology, was recognized with distinction as the Charles F. Mathy Professor in Melanoma Research View Related
Mayo Clinic Cancer Center researcher, Diane F. Jelinek, Ph.D., a consultant in the Department of Immunology at Mayo Clinic in Rochester, received the Gene and Mary Lou Kurtz Professorship in Multiple Myeloma Research. View Related 
William C. Rupp, M.D., has been appointed CEO for the Florida campus effective Nov. 21, Mayo Clinic announced today. Rupp currently leads quality projects for Luther Midelfort, part of Mayo Health System, as well as Mayo Clinic.
Publication: The Journal of Cell Biology -- Sept. 22, 2008 In collaboration with the University of Minnesota 
Mayo Clinic researchers have discovered that an antibody, previously identified as a treatment for cancer, also diminishes the overactive immune responses in asthma. 
Cancer Center member Larry Pease, Ph.D., chair of the Department of Immunology and a professor in the Departments of Immunology, and Biochemistry and Molecular Biology, received the Gordon H. and Violet Bartels Professorship in Cellular Biology. View Related 
Potentially, this vaccine could be used as a complementary tool with tamoxifen, a widely used estrogen therapy used as a temporary post-treatment approach to prevent the return of tumors. Breast cancer is second only to lung cancer as a killer of women. In 1998-2002, according to the American Cancer Society, 95 percent of new cases and 97 percent of deaths occurred in women 40 and older in the United States. However, early diagnosis and treatment have led to increasing survival rates in the last 25 years. There are more than two million breast cancer survivors in the United States today. Breast cancer is second only to lung cancer as a killer of women. In 1998-2002, according to the American Cancer Society, 95 percent of new cases and 97 percent of deaths occurred in women 40 and older in the United States. However, early diagnosis and treatment have led to increasing survival rates in the last 25 years. There are more than two million breast cancer survivors in the United States today. View Related
Implications of aging and self-tolerance on the generation of immune and antitumor immune responses.
Publication: Cancer Research -- July 1, 2008
Publication: Cancer Research -- June 15, 2008
Discovery's Edge Disease should not be an eventual part of aging, yet something happens as we near retirement age that makes a variety of cancers far more likely. Joseph Lustgarten, Ph.D., and his colleagues at Mayo Clinic are focusing on changes in the immune system, trying to find a connection, a cause, and then a therapy. 
Medial Edge Newspaper An international team of researchers led by Mayo Clinic recently designed a technique that uses the body's own cells and a virus to destroy cancer cells that spread from primary tumors to other parts of the body through the lymphatic system. In addition, the team's research indicates that this technology could be the basis for a new cancer vaccine to prevent cancer recurrence. View Related
Agreement strengthens relationship and spawns new scientific collaborations "TGen takes seriously our commitment to work toward helping patients with cancer and other disorders. This announcement is another mechanism allowing TGen and Mayo faculty to work bi-directionally in a more seamless fashion," said Jeffrey Trent, Ph.D., TGen's president and scientific director. View Related 
Named professorships at Mayo Clinic represent the highest academic distinction for a faculty member. Sandra Gendler, Ph.D., was named the David F. and Margaret T. Grohne Research Professor in Therapeutics for Cancer Research. Richard Vile, Ph.D., a consultant in the Department of Molecular Medicine and Department of Immunology at Mayo Clinic Rochester, was honored with The Richard M. Schulze Family Foundation Professorship. 
Research into the B7 molecules has been a "family affair" at Mayo. Many Mayo immunologists have joined together to tackle various aspects of their function and behavior and have discovered how they function.
Mayo Clinic Cancer Center had researchers from many disciplines presenting more than 60 oral abstracts and dozens of posters, also educational sessions and other special events throughout the 2007 ASCO program, June 1-5. View Related 
The National Institutes of Health chose Mayo Clinic as one of the first 12 institutions to receive Clinical and Translational Science Awards (CTSA) in October 2006. "There are two objects in medical education: to heal the sick and advance the science." - Dr. Charles H. Mayo 
Yuan-Ping Pang, Ph.D. established the Computer-Aided Molecular Design Laboratory (CAMDL) to learn more about how biological systems function and to establish models that could lead to new treatments for infectious diseases and cancer. View Related 
The Clinical Research Training Program provides a formal education in all aspects of clinical research, including grant-writing, legal and ethical issues, statistics, epidemiology and study design and protocols. "I realized how exciting research can be, and how exciting it is to advance the science." Jon Ebbert, M.D. View Related
Immunotherapy has significant potential for eradicating many types of cancer and enabling cancer patients to live normal lives. A federation of 20 Mayo Clinic laboratories with multidisciplinary focus, the Department of Immunology is one of the largest within Mayo Clinic's research domain. It is regarded by peers as one of the top research departments in the country, with a distinguished publishing record. Because its creative collaborations are so numerous and productive, its pathbreaking findings regularly appear in top biomedical journals. View Related
In helping young investigators, Mayo Clinic again is connecting all the dots -- leading back to the same point, the same mission, ongoing and yet unchanged for over a century: the needs of the patient come first. New, young investigators are critical to biomedical research. Their fresh ideas, innovativeness, and enthusiasm are necessary for scientific progress. Yet the steps from a junior research position toward a self-sufficient laboratory can be difficult. Mayo Clinic is dedicated to fostering future, investigators. Here we look at two of them and what Mayo is doing to help. View Related
While the incidence of most cancers has been declining, that of non-Hodgkin's lymphoma has been on the rise. It is the fifth most common type of cancer diagnosed in the United States, with an estimated 300,000 Americans currently living with the disease. Radio-Immunotherapy Holds Promise for Patients with Lymphoma "I'm sorry, Mrs. Wolter, but your cancer is back." Charlotte Wolter had heard this before. The Glencoe, Minn., resident had endured seven months of chemotherapy. And now, after participating in a clinical trial she had hoped would put her cancer into remission, she was hearing the words again. For Wolter and many other patients battling B-cell non-Hodgkin's lymphoma, chemotherapy and radiation often result in tumors shrinking but recurring in the same or other locations. At the same time, there is no cure for the disease. These patients brave difficult treatment regimens, endure a host of side effects, yet still fail to hear those magic words: you're cancer-free. But now a new drug, known as Zevalin, is giving hope to patients who no longer respond to other treatment options. For patients like Wolter, Zevalin appears to be a wish come true. View Related
Publication: Journal of Clinical Oncology -- Dec. 20, 2005 Results of a pooled analysis from the North Central Cancer Treatment Group View Related 
|
LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE
Use of this site signifies your agreement to the terms of use.
© 2012 Mayo Foundation for Medical Education and Research. All rights reserved.
